2290
N. E. Poopeiko et al. / Bioorg. Med. Chem. Lett. 13(2003) 2285–2290
20. Rajwanshi, V. K.; Kumar, R.; Kofod-Hansen, M.; Wen-
gel, J. J. Chem. Soc., Perkin Trans. 1 1999, 1407.
33. 1-(2-Amino-2-deoxy-2-N,4-C-methylene-2-N-trifluoroacetyl-
b-d-xylofuranosyl)thymine (19) [major rotamer (rotamer ratio
1
21. Rajwanshi, V. K.; Ha
gel, J. Chem. Commun. 1999, 1395.
22. Rajwanshi, V. K.; Hakansson, A. E.; Kumar, R.; Wengel,
˚
kansson, A. E.; Dahl, B. M.; Wen-
2:3)]: H NMR(400 MHz, ((CD ) SO) d 11.25 (bs, 1H, NH),
3 2
7.53 (d, J=1.3 Hz, 1H, H-6), 5.98 (bs, 1H, 30-OH), 5.59 (s,
1H, H-10), 5.14 (t, J=5.7 Hz, 1H, 50-OH), 4.65 (br s, 1H,
H-20), 4.18 (t, J=2.4 Hz, 1H, H-30), 3.92–3.84 (m, 2H, H-50),
3.68 (d, J=11.9 Hz, 1H, H-500), 3.42 (d, J=11.9, 1H, H-500),
1.76 (s, 3H, CH3); 13C NMR(100.6 MHz, ((CD 3)2SO)) d
164.10, 154.18 (q, J=37.4 Hz), 150.02, 136.78, 115.75 (q,
J=287.3 Hz), 106.13, 89.22, 87.88, 72.30, 60.82, 57.12, 53.19,
12.50.
˚
J. Chem. Commun. 1999, 2073.
23. The term ‘XNA’ is defined herein as an oligonucleotide
containing one or more xylo-configured nucleotide monomers
(‘XNA-monomer(s)’).
24. Kong, J. P.; Kim, S. K.; Moon, B. J.; Kim, S. J.; Kim,
H. B. Nucleosides Nucleotides 2001, 20, 1751. We used sodium
hydroxide instead of lithium hydroxide during reaction on the
30-O-mesylated intermediate.
34. 1-(2-Amino-3-O-((2-cyanoethoxy)(N,N-diisopropylamino)-
phosphino)-2-deoxy-5-O-(4,40-dimethoxytrityl)-2-N,4-C-meth-
ylene-2-N-trifluoroacetyl-b-d-xylofuranosyl)thymine (21): 31P
25. Wright, J. A.; Wilson, D. P.; Fox, J. J. J. Med. Chem.
1970, 13, 269.
NMR(400 MHz, CH CN) d 154.9, 154.2, 152.5, 152.3.
3
26. 1-(2-Deoxy-2-fluoro-b-d-xylofuranosyl)thymine (5b): 1H
NMR(300 MHz, CD 3OD) d 7.71 (s, 1H, H-6), 6.02 (d, 1H,
J=21.4 Hz, H-10), 4.95 (d, 1H, J=49.4 Hz, H-20), 4.35 (dd,
1H, J=3.3 and 10.4 Hz, H-30), 4.26–4.21 (m, 1H, H-40), 4.00–
3.86 (m, 2H, H-50), 1.86 (br s, 3H, CH3); 13C NMR
(75.5 MHz, CD3OD; selected signals) d 138.5, 111.0, 100.7
(J=184.9), 90.4 (J=38.4), 85.0, 73.8 (J=25.8), 60.7, 12.6.
27. Michalik, M.; Hein, M.; Michael, F. Carbohydr. Res.
2000, 327, 185.
28. Kowollik, G.; Langen, P. Z. Chem. 1975, 15, 147.
29. Lemieux, R. U.; Lineback, D. R. Ann. Rev. Biochem.
1963, 32, 155.
30. Mikhailopulo, I. A.; Poopeiko, N. E.; Pricota, T. I.;
Sivets, G. G.; Kvasyuk, E. I.; Balzarini, J.; De Clercq, E. J.
Med. Chem. 1991, 34, 2195 and references cited therein.
31. 1-(3-O-((2-Cyanoethoxy)(N,N-diisopropylamino)phosphino)
-2-deoxy-5-O-(4,40 -dimethoxytrityl)-2-fluoro-b-d -xylofur-
anosyl)thymine (7): 31P NMR(300MHz, CH 3CN) d 153.8 and
151.2.
35. Altona, C.; Sundaralingam, M. J. Am. Chem. Soc. 1972,
94, 8205.
36. Altona, C.; Sundaralingam, M. J. Am. Chem. Soc. 1973,
95, 2333.
37. Caruthers, M. H. Acc. Chem. Res. 1991, 51, 2155.
˚
38. Hakansson, A. E.; Koshkin, A. A.; Sørensen, M. D.;
Wengel, J. J. Org. Chem. 2000, 65, 5161.
39. MALDI-MS m/z ([M-H]ꢀ; found/calcd) ON4, 2776/2778;
ON6, 2833/2833; ON7, 2834/2834; ON9, 4191/4197; ON10,
4210/4215; ON11, 4220/4221; ON12, 4191/4197; ON14, 4247/
4251; ON15, 4300/4302.
40. Ivanov, S. A.; Alekseev, Y. I.; Gottikh, M. B. Mol. Biol.
2002, 36, 131.
41. Hybridization was performed in 100 mM NaCl, 10 mM
KCl, 20 mM Tris–HCl (pH 7.5) by heating to 65 ꢂC, slowly
cooling after 2 min to 37 ꢂC followed by incubation at 5 ꢂC for
1–2 h. The resulting complexes were then analyzed on 20%
acrylamide gels run at approximately 14 ꢂC.
42. Egholm, M.; Buchardt, O.; Nielsen, P. E.; Berg, R. H.
J. Am. Chem. Soc. 1992, 114, 1895.
43. Poopeiko, N. E.; Juhl, M.; Vester, B.; Wengel, J.
Manuscript in preparation.
32. Sørensen, M. D.; Kværnø, L.; Bryld, T.; Hakansson, A. E.;
˚
Verbeure, B.; Gaubert, G.; Herdewijn, P.; Wengel, J. J. Am.
Chem. Soc. 2002, 124, 2164.